New spinal fluid marker may sharpen Alzheimer's diagnosis
NCT ID NCT02770482
First seen Jan 24, 2026 · Last updated May 14, 2026 · Updated 11 times
Summary
This study looked at whether measuring a protein called amyloid beta 1-40 in spinal fluid can help doctors diagnose Alzheimer's disease more reliably. Current tests sometimes give unclear results. The study involved 204 people with memory problems. Researchers measured the ratio of two proteins (Aβ42/Aβ40) to see if it improves diagnostic certainty.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu de Reims
Reims, 51092, France
Conditions
Explore the condition pages connected to this study.